Onsdag 18 Februari | 17:41:08 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-02-11 08:30 Bokslutskommuniké 2026
2026-11-05 08:30 Kvartalsrapport 2026-Q3
2026-07-17 08:30 Kvartalsrapport 2026-Q2
2026-05-21 N/A X-dag ordinarie utdelning ORGC 0.00 SEK
2026-05-20 N/A Årsstämma
2026-05-06 08:30 Kvartalsrapport 2026-Q1
2026-02-12 - Bokslutskommuniké 2025
2025-11-05 - Kvartalsrapport 2025-Q3
2025-08-05 - Extra Bolagsstämma 2025
2025-07-18 - Kvartalsrapport 2025-Q2
2025-05-21 - X-dag ordinarie utdelning ORGC 0.00 SEK
2025-05-20 - Årsstämma
2025-05-06 - Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-07-19 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning ORGC 0.00 SEK
2024-05-15 - Årsstämma
2024-04-30 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning ORGC 0.00 SEK
2023-05-17 - Årsstämma
2023-05-05 - Kvartalsrapport 2023-Q1
2023-02-15 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-17 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning ORGC 0.00 SEK
2022-05-17 - Årsstämma
2022-05-04 - Kvartalsrapport 2022-Q1
2022-02-18 - Bokslutskommuniké 2021
2022-01-12 - Extra Bolagsstämma 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-18 - X-dag ordinarie utdelning ORGC 0.00 SEK
2021-05-17 - Årsstämma
2021-05-05 - Kvartalsrapport 2021-Q1
2021-02-17 - Bokslutskommuniké 2020
2020-11-10 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-08 - X-dag ordinarie utdelning ORGC 0.00 SEK
2020-05-07 - Årsstämma
2020-05-06 - Kvartalsrapport 2020-Q1
2020-02-18 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-05-17 - X-dag ordinarie utdelning ORGC 0.00 SEK
2019-05-16 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-20 - Bokslutskommuniké 2018
2018-11-08 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-16 - Årsstämma
2018-05-09 - Kvartalsrapport 2018-Q1
2018-05-04 - X-dag ordinarie utdelning ORGC 0.00 SEK
2018-05-03 - Årsstämma
2018-02-22 - Bokslutskommuniké 2017
2017-11-09 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-31 - X-dag ordinarie utdelning ORGC 0.00 SEK
2017-05-30 - Årsstämma
2017-05-10 - Kvartalsrapport 2017-Q1
2017-02-22 - Bokslutskommuniké 2016
2016-12-19 - Extra Bolagsstämma 2016
2016-11-11 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-11 - X-dag ordinarie utdelning ORGC 0.00 SEK
2016-05-10 - Årsstämma
2016-05-10 - Kvartalsrapport 2016-Q1
2016-02-24 - Bokslutskommuniké 2015
2015-11-11 - Kvartalsrapport 2015-Q3
2015-08-21 - Kvartalsrapport 2015-Q2
2015-05-26 - Kvartalsrapport 2015-Q1
2015-05-05 - Årsstämma
2015-03-31 - Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriForskning & Utveckling
OrganoClick är verksamt inom miljöteknik. Bolaget erbjuder specialiserade lösningar baserat på fiberbaserat material, där bolaget utvecklar, producerar och marknadsför funktionell fiberkemi. Produkterna används huvudsakligen inom vattenavvisande tyg och främst inom träbehandling för att beskydda mot svampförfall och brand. Bolaget grundades år 2006 och har sitt huvudkontor i Täby.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-08-06 17:04:17
OrganoClick AB (publ) ("OrganoClick" or the "Company") has prepared and today publishes an information memorandum for the upcoming issue of shares with preferential rights for existing shareholders (the "Rights Issue"), which the Company's Board of Directors proposed on July 17, 2025 and which the Company's Extraordinary General Meeting resolved on August 5, 2025. In order to provide a more comprehensive basis for decision-making regarding the upcoming rights issue, the Company has prepared an information memorandum containing background, motives and complete terms and conditions and instructions for the rights issue. The information memorandum is attached to this press release and is available on the Company's website, (https://organoclick.com/about/corporate-governance/general-meeting/)

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE THE ANNOUNCEMENT, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION MEASURES. 

SUMMARY OF THE OFFER

Rights issue
The issue comprises a maximum of 11,543,290 shares, and can generate up to SEK 20.3 million for the Company before issue costs, which are estimated at approximately 2 percent (SEK 0.4 million) of the issue amount.

Preferential Rights and Record Date
The last day for trading in the shares including the right to participate in the New Issue is August 4, 2025 and the first day for trading in the shares excluding the right to participate in the New Issue is August 5, 2025. The record date is August 6, 2025.
Shareholders in the Company receive two (2) subscription rights for one (1) share held. Seventeen (17) subscription rights are required to subscribe for one (1) new share.


Subscription period
August 8 - August 22, 2025.

Subscription price
SEK 1.76/share. No brokerage fee is charged.

Number of shares before the New Issue
98,117,967 shares.

Trading in subscription rights
Trading in subscription rights will take place on First North during the period 8-19 August 2025.

Information about the share
Trading venue: Nasdaq First North Growth Market
Short name: ORGC
ISIN code: SE0006510335


Subscription commitments
In connection with the Offer, OrganoClick has received subscription and guarantee commitments corresponding to 100% of the Rights Issue from the Company’s three largest shareholders pro-rata in accordance with the table in the information memorandum. No remuneration is paid for these subscription commitments.

Advisors

Advokatfirman Delphi is acting as legal advisor to the Company in connection with the Rights Issue. Eminova Fondkommission has been engaged as issuing agent in connection with the Rights Issue.

For more information, terms and conditions and instructions, see attached information memorandum.